Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
VYGR Voyager Therapeutics, Inc. daily Stock Chart
VYGR [NASD]
Voyager Therapeutics, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.63 Insider Own6.29% Shs Outstand36.88M Perf Week-3.72%
Market Cap496.40M Forward P/E- EPS next Y-2.90 Insider Trans0.00% Shs Float31.58M Perf Month-5.48%
Income-53.60M PEG- EPS next Q-0.83 Inst Own83.40% Short Float9.20% Perf Quarter-25.80%
Sales73.70M P/S6.74 EPS this Y-4.40% Inst Trans5.09% Short Ratio7.32 Perf Half Y-49.68%
Book/sh2.94 P/B4.58 EPS next Y-77.90% ROA-15.80% Target Price29.42 Perf Year27.95%
Cash/sh8.34 P/C1.61 EPS next 5Y- ROE-57.30% 52W Range7.76 - 28.79 Perf YTD43.19%
Dividend- P/FCF11.60 EPS past 5Y- ROI-195.90% 52W High-53.25% Beta2.49
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin- 52W Low73.45% ATR0.77
Employees123 Current Ratio4.10 Sales Q/Q871.40% Oper. Margin-82.90% RSI (14)44.24 Volatility5.41% 5.57%
OptionableYes Debt/Eq0.00 EPS Q/Q35.20% Profit Margin-72.60% Rel Volume1.24 Prev Close13.39
ShortableYes LT Debt/Eq0.00 EarningsNov 06 BMO Payout- Avg Volume397.15K Price13.46
Recom1.80 SMA20-2.01% SMA50-7.79% SMA200-31.49% Volume493,995 Change0.52%
Nov-15-18Upgrade Raymond James Outperform → Strong Buy
Sep-10-18Resumed BTIG Research Buy $32
Sep-10-18Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-04-18Initiated H.C. Wainwright Buy $30
Mar-12-18Downgrade Wedbush Outperform → Neutral $29
Mar-12-18Downgrade Evercore ISI Outperform → In-line
Feb-02-18Initiated Morgan Stanley Overweight
Nov-28-17Resumed Piper Jaffray Overweight $28
Oct-31-17Initiated Robert W. Baird Outperform $31
Oct-27-17Initiated Canaccord Genuity Buy $35
Oct-23-17Reiterated Stifel Buy $20 → $31
Oct-12-17Initiated Raymond James Outperform $35
Aug-17-17Initiated Evercore ISI Outperform $12
Jul-28-17Resumed Stifel Buy $20
Mar-16-17Reiterated Chardan Capital Markets Neutral $11 → $13
Mar-02-17Initiated Instinet Buy $31
Jul-15-16Initiated Stifel Buy $33
May-20-16Initiated Wells Fargo Outperform
Jan-25-16Upgrade Chardan Capital Markets Sell → Neutral $15
Dec-09-15Initiated Chardan Capital Markets Sell $20
Dec-11-19 10:32AM  Is Voyager Therapeutics, Inc. (VYGR) Going To Burn These Hedge Funds ? Insider Monkey
Nov-12-19 09:05PM  Edited Transcript of VYGR earnings conference call or presentation 6-Nov-19 1:00pm GMT Thomson Reuters StreetEvents
Nov-06-19 07:35AM  Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates Zacks -7.34%
06:22AM  Voyager Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Highlights GlobeNewswire
Oct-31-19 08:00AM  Voyager Therapeutics to Present at the Credit Suisse Healthcare Conference GlobeNewswire
Oct-30-19 04:35PM  Voyager Therapeutics to Host Third Quarter 2019 Financial Results and Corporate Highlights Conference Call GlobeNewswire
10:33AM  Earnings Preview: Voyager Therapeutics (VYGR) Q3 Earnings Expected to Decline Zacks
Oct-28-19 04:14PM  Is Voyager Therapeutics, Inc. (VYGR) Going To Burn These Hedge Funds ? Insider Monkey
Sep-25-19 08:00AM  Voyager Therapeutics to Present at Upcoming Investor Conferences in October 2019 GlobeNewswire
Sep-24-19 09:00AM  CSE New Listing - Voyager Digital (Canada) Ltd Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com Newsfile -6.70%
Sep-02-19 01:07AM  Edited Transcript of VYGR earnings conference call or presentation 9-Aug-19 12:00pm GMT Thomson Reuters StreetEvents
Aug-28-19 08:00AM  Voyager Therapeutics to Present at Upcoming Investor Conferences in September 2019 GlobeNewswire
Aug-09-19 09:23PM  Voyager Therapeutics, Inc. (VYGR) Q2 2019 Earnings Call Transcript Motley Fool
08:25AM  Voyager Therapeutics (VYGR) Q2 Earnings and Revenues Top Estimates Zacks
07:00AM  Voyager Therapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights GlobeNewswire
Aug-05-19 04:30PM  Voyager Therapeutics to Host Second Quarter 2019 Financial Results and Corporate Highlights Conference Call GlobeNewswire
Aug-02-19 06:04AM  5 years later, Ice Bucket Challenge's impact on drug research still unfolding American City Business Journals
Jul-30-19 04:30PM  Voyager Therapeutics to Present at Upcoming Investor Conferences in August 2019 GlobeNewswire
10:38AM  Earnings Preview: Voyager Therapeutics (VYGR) Q2 Earnings Expected to Decline Zacks
Jul-08-19 10:53AM  Are Voyager Therapeutics, Inc. (NASDAQ:VYGR) Investors Paying Above The Intrinsic Value? Simply Wall St.
Jun-18-19 10:47AM  Did Hedge Funds Drop The Ball On Voyager Therapeutics, Inc. (VYGR) ? Insider Monkey
07:31AM  The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale Benzinga
Jun-17-19 07:30AM  Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update GlobeNewswire +10.35%
Jun-11-19 04:30PM  Voyager Therapeutics to Present at the Raymond James Life Sciences & MedTech Conference GlobeNewswire
May-30-19 02:36PM  3 Top Gene Therapy Stocks That Could Soar InvestorPlace
May-20-19 04:30PM  Voyager Therapeutics Announces Management Updates GlobeNewswire
May-07-19 08:35AM  Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:27AM  Voyager Therapeutics: 1Q Earnings Snapshot Associated Press
07:05AM  Voyager Therapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights GlobeNewswire
May-05-19 09:05AM  Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinsons Disease at the American Academy of Neurology Annual Meeting GlobeNewswire
May-02-19 10:32AM  Analysts Estimate Voyager Therapeutics (VYGR) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-30-19 10:37AM  What Are Analysts Expecting From Voyager Therapeutics, Inc. (NASDAQ:VYGR) Over The Next Few Years? Simply Wall St.
Apr-29-19 07:04AM  Voyager Therapeutics Announces New Data in Multiple Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting GlobeNewswire
Apr-15-19 12:25PM  Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting GlobeNewswire
Apr-03-19 04:15PM  Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c)(4) GlobeNewswire
Apr-02-19 04:15PM  Voyager Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire +7.38%
Mar-28-19 04:15PM  Neurocrine Biosciences and Voyager Therapeutics Announce Publication of Phase 1b Trial Results of VY-AADC for Parkinsons Disease in the Annals of Neurology GlobeNewswire
Mar-11-19 08:00AM  MRI Interventions Announces Collaboration with Voyager Therapeutics for the Design, Manufacture and Supply of V-TAG Device GlobeNewswire +7.28%
Mar-10-19 10:36AM  10 Stocks For The Gene Therapy Revolution Investopedia
Mar-08-19 08:00AM  Rare Disease Therapies Draw Big Biopharma's Interest ACCESSWIRE
Mar-06-19 07:50AM  Consolidated Research: 2019 Summary Expectations for AMC Entertainment, Spirit Airlines, Voyager Therapeutics, CIT Group, Kaman, and CommVault Fundamental Analysis, Key Performance Indications GlobeNewswire -5.29%
Mar-04-19 05:03PM  Here's Why Voyager Therapeutics Stock Rose as Much as 13% Today Motley Fool +10.24%
Mar-01-19 09:29PM  Why Big Pharma Is Diving Into Gene Therapy Barrons.com +10.00%
Feb-28-19 10:32PM  Edited Transcript of VYGR earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-26-19 09:22PM  Voyager Therapeutics, Inc. (VYGR) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:05PM  Voyager Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights GlobeNewswire
Feb-25-19 08:19AM  AbbVie Extends Deal With Voyager to Make Parkinson's Drugs Zacks +5.64%
Feb-22-19 02:40PM  Watch These Four Biotech Stocks Friday ACCESSWIRE +22.85%
12:25PM  Why Voyager Therapeutics Is Skyrocketing Today Motley Fool
11:31AM  Voyager Therapeutics stock jumps on 2nd Parkinson's deal American City Business Journals
09:46AM  Voyager Shares Take Off on Parkinson's Disease Development Deal TheStreet.com
08:10AM  Voyager Therapeutics stock soars after AbbVie collaboration potentially valued at over $1 billion MarketWatch
08:00AM  Voyager Therapeutics and AbbVie Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinsons Disease and Other Synucleinopathies GlobeNewswire
08:00AM  AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies PR Newswire
Feb-19-19 08:00AM  Voyager Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire
Feb-18-19 08:00AM  Voyager Therapeutics to Host Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights Conference Call GlobeNewswire
Feb-13-19 08:15AM  Voyager Launches Highly Anticipated Retail Mobile App for Commission-Free Crypto Asset Trading Business Wire
Feb-05-19 08:04PM  Neurocrine Biosciences Inc (NBIX) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-04-19 03:41PM  Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q3 Zacks
Feb-01-19 02:11PM  German firm that serves gene therapy biotechs opens Cambridge HQ American City Business Journals
Jan-31-19 02:45PM  Here are Boston-area biotechs pursuing Parkinson's treatments American City Business Journals
Jan-30-19 08:05AM  Today's Research Reports on Trending Tickers: Voyager Therapeutics and Conatus Pharmaceuticals ACCESSWIRE -5.40%
Jan-29-19 01:42PM  Here's Why Voyager Therapeutics Stock Soared as Much as 62.9% Today Motley Fool +38.31%
07:00AM  Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinsons Disease and Friedreichs Ataxia GlobeNewswire
Jan-16-19 07:40AM  Consolidated Research: 2019 Summary Expectations for Southern, Exelon, PriceSmart, Five Prime Therapeutics, Digi International, and Voyager Therapeutics Fundamental Analysis, Key Performance Indications GlobeNewswire
Jan-15-19 07:03AM  Voyager Therapeutics to Appoint Omar Khwaja, M.D., Ph.D., as Chief Medical Officer GlobeNewswire
Jan-07-19 07:07AM  Voyager Therapeutics Provides Updates for VY-AADC Clinical Program for Parkinsons Disease GlobeNewswire
Dec-17-18 07:10AM  Voyager Therapeutics Joins Michael J. Fox Foundation Initiatives and Education Campaigns to Accelerate the Development of New therapies and a Cure for Parkinsons Disease GlobeNewswire
Dec-15-18 01:54AM  Should You Buy Voyager Therapeutics, Inc. (VYGR)? Insider Monkey
Dec-10-18 07:10AM  Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinsons Disease GlobeNewswire
Nov-29-18 07:04AM  Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies GlobeNewswire
Nov-23-18 08:10AM  Report: Exploring Fundamental Drivers Behind Graphic Packaging Holding, QEP Resources, Inogen, CytRx, Voyager Therapeutics, and Daily Journal Corp. (S.C.) New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-20-18 07:52AM  Edited Transcript of VYGR earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-19-18 04:21PM  Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference GlobeNewswire -6.91%
Nov-08-18 08:10AM  The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering Benzinga -11.97%
Nov-07-18 06:09PM  Voyager Therapeutics: 3Q Earnings Snapshot Associated Press
04:10PM  Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Highlights GlobeNewswire
04:10PM  Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinsons Disease GlobeNewswire
Oct-31-18 06:30AM  Voyager Therapeutics to Host Third Quarter 2018 Financial Results and Corporate Highlights Conference Call GlobeNewswire
Oct-16-18 07:03AM  Voyager Therapeutics Announces Preclinical Data for Huntingtons Disease and Amyotrophic Lateral Sclerosis Programs at the Congress of the European Society of Gene and Cell Therapy GlobeNewswire +5.47%
Sep-24-18 01:23PM  Voyager Therapeutics Inc (NASDAQ:VYGR): Time For A Financial Health Check Simply Wall St.
Aug-28-18 11:53AM  Voyager Therapeutics to Present at Investor Conferences in September GlobeNewswire
Aug-07-18 07:45PM  Voyager Therapeutics (VYGR) Reports Q2 Loss, Misses Revenue Estimates Zacks
06:41PM  Voyager Therapeutics: 2Q Earnings Snapshot Associated Press
04:07PM  Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights GlobeNewswire
02:30PM  Voyager Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:26AM  Voyager Therapeutics to Present at Investor Conferences in August GlobeNewswire
Jul-31-18 04:59PM  Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights Conference Call GlobeNewswire
Jul-30-18 07:20AM  Breakfast Technical Briefing on ZIOPHARM Oncology and Three Other Additional Biotech Stocks ACCESSWIRE
Jul-21-18 08:44AM  Canaccord Previews Biotech Catalysts In The Second Half: Neurological Drugs In Focus Benzinga
Jul-17-18 07:04AM  Voyager Therapeutics Receives FDA Guidance on Development Path for VY-AADC for Parkinsons Disease and Provides Clinical Update GlobeNewswire +10.37%
Jul-02-18 07:25AM  Initiating Free Research Reports on ZIOPHARM Oncology and Three Other Biotech Equities ACCESSWIRE
Jun-28-18 04:30PM  Voyager Therapeutics Appoints Andre Turenne as President and Chief Executive Officer GlobeNewswire -6.71%
Jun-21-18 08:54AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +6.28%
07:03AM  Voyager Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for VY-AADC for the Treatment of Parkinsons Disease GlobeNewswire
May-30-18 07:25AM  Complimentary Technical Snapshots on VIVUS and Three More Biotech Stocks ACCESSWIRE
May-29-18 04:30PM  Voyager Therapeutics Announces Management Change GlobeNewswire
May-18-18 06:30PM  Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting GlobeNewswire -7.72%
08:00AM  Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved Benzinga
May-17-18 06:15PM  Voyager Therapeutics Announces New Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting GlobeNewswire
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD101 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia; and VY-NAV01 for severe chronic pain. The company has strategic collaboration agreements with AbbVie Inc.; the University of Massachusetts; and MRI Interventions, Inc., as well as collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies to support the development of its gene therapy programs. It also has a collaboration and license agreement with Neurocrine Biosciences, Inc. for the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NEUROCRINE BIOSCIENCES INC10% OwnerMar 12Buy11.964,179,72849,999,9964,179,728Mar 14 04:34 PM
open in yahoo | open in reuters | open in google